The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
71MZasEsycW3kY3G
